论文部分内容阅读
A total of 12 patients with metastatic hormone refractory prostate cancer were treated by combining cryoablation and granulocyte macrophage colony-stimulating factor administration.Besides prostate-specific antigen (PSA) measurements,peripheral blood mononuclear cells were also obtained; the frequency of tumor-specific T cells was tested ex vivo in an interferon-γ enzyme-linked immunospot assay after stimulating with autologous prostate cancer-derived protein lysates.